The Diagnostic and Prognostic Significance of ARID1A and CD8+ Expression in Endometrial Hyperplasia and Endometrial Endometrioid Adenocarcinoma (Immunohistochemical study)
El Sawi, R., Hassan, A., Youssef, S., Agina, H., Ahmed, H., Ibrahim, E. (2022). The Diagnostic and Prognostic Significance of ARID1A and CD8+ Expression in Endometrial Hyperplasia and Endometrial Endometrioid Adenocarcinoma (Immunohistochemical study). EKB Journal Management System, 39(Special issue (Academic)), 294-318. doi: 10.21608/bmfj.2022.156719.1642
Rasha Mohammed El Sawi; Amany Hassan; Samia Ahmed Youssef; Hala Adel Agina; Hanan Ahmed; Enas Ibrahim. "The Diagnostic and Prognostic Significance of ARID1A and CD8+ Expression in Endometrial Hyperplasia and Endometrial Endometrioid Adenocarcinoma (Immunohistochemical study)". EKB Journal Management System, 39, Special issue (Academic), 2022, 294-318. doi: 10.21608/bmfj.2022.156719.1642
El Sawi, R., Hassan, A., Youssef, S., Agina, H., Ahmed, H., Ibrahim, E. (2022). 'The Diagnostic and Prognostic Significance of ARID1A and CD8+ Expression in Endometrial Hyperplasia and Endometrial Endometrioid Adenocarcinoma (Immunohistochemical study)', EKB Journal Management System, 39(Special issue (Academic)), pp. 294-318. doi: 10.21608/bmfj.2022.156719.1642
El Sawi, R., Hassan, A., Youssef, S., Agina, H., Ahmed, H., Ibrahim, E. The Diagnostic and Prognostic Significance of ARID1A and CD8+ Expression in Endometrial Hyperplasia and Endometrial Endometrioid Adenocarcinoma (Immunohistochemical study). EKB Journal Management System, 2022; 39(Special issue (Academic)): 294-318. doi: 10.21608/bmfj.2022.156719.1642

The Diagnostic and Prognostic Significance of ARID1A and CD8+ Expression in Endometrial Hyperplasia and Endometrial Endometrioid Adenocarcinoma (Immunohistochemical study)

Benha Medical Journal
Article 301, Volume 39, Special issue (Academic), September and October 2022, Page 294-318  XML PDF (1.41 MB)
Document Type: Original Article
DOI: 10.21608/bmfj.2022.156719.1642
View on SCiNiTO View on SCiNiTO
Authors
Rasha Mohammed El Sawi1; Amany Hassan2; Samia Ahmed Youssef1; Hala Adel Agina3; Hanan Ahmed email 1; Enas Ibrahim4
1Department of Pathology, Faculty of Medicine, Benha University, Egypt
2Department of Pathology, Faculty of Medicine, Mansoura University, Mansura, Egypt
3Department of pathology, Faculty of Medicine, Benha university, Egypt
4Department of Pathology, Faculty of medicine, Benha university, Egypt
Abstract
Background: Epigenetic driver mutations and tumor microenvironment could play an important and promising role in diagnosis, prognosis, and prediction of different endometrial lesions.
Aim: To determine their putative diagnostic and prognostic value, this work analyzes the immunohistochemical (IHC) expression of ARID1A and CD8+ in endometrial hyperplasia (EH) and endometrioid endometrial adenocarcinoma (EEA).
Material and methods: The 80 distinct endometrial lesions included in this retrospective study included (20) EH without atypia, (30) atypical EH (AEH), and (30) EEA. Clinicopathological characteristics and survival of examined cases were correlated with the IHC expression of ARID1A and CD8+.
Results: ARID1A negative expression was significantly associated with EEA (46.7%) and AEH (30%), while its positivity was associated with EH without atypia cases (100%) (P
Keywords
ARID1A; CD8+; Endometrial hyperplasia; Endometrioid adenocarcinoma
Statistics
Article View: 305
PDF Download: 335